                         SEQUENCE LISTING

<110>  Zealand Pharma A/S
 
<120>  Pharmaceutical Parenteral Composition of Dual GLP1/2 Agonist

<130>  P119722PCT1

<150>  EP19180233.9
<151>  2019-06-14

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is [Aib]

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is an L or D lysine residue in which the side chain is 
       conjugated to the GLP-1/GLP-2 dual agonist and wherein said side 
       chain is [K([17-carboxy-heptadecanoyl]-isoGlu)]

<400>  1

His Xaa Glu Gly Ser Phe Thr Ser Glu Leu Ala Thr Ile Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Arg Asp Phe Ile Ala Trp Leu Ile Gln His Lys Ile Thr 
            20                  25                  30          


Asp 
    


<210>  2
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is [Aib]

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is T or S (wherein at least one of X5 and X7 is T)

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is T or S (wherein at least one of X5 and X7 is T)

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is an L or D lysine residue in which the side chain is 
       conjugated to the GLP-1/GLP-2 dual agonist

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Q, E, A, H, Y, L, K, R or S

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  Xaa is H, Y or Q

<400>  2

His Xaa Glu Gly Xaa Phe Xaa Ser Glu Leu Ala Thr Ile Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Arg Asp Phe Ile Ala Trp Leu Ile Xaa Xaa Lys Ile Thr 
            20                  25                  30          


Asp 
    


<210>  3
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is [Aib]

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is T or S

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is an L or D lysine residue in which the side chain is 
       conjugated to the GLP-1/GLP-2 dual agonist and wherein said side 
       chain is [K([17-carboxy-heptadecanoyl]-isoGlu)]

<220>
<221>  MISC_FEATURE
<222>  (28)..(28)
<223>  Xaa is Q, E, A, H, Y, L, K, R or S

<400>  3

His Xaa Glu Gly Xaa Phe Thr Ser Glu Leu Ala Thr Ile Leu Asp Xaa 
1               5                   10                  15      


Gln Ala Ala Arg Asp Phe Ile Ala Trp Leu Ile Xaa His Lys Ile Thr 
            20                  25                  30          


Asp 
    


